CHINYERE IHUNNAH
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care DALLAS, TX NPI 1821683525
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care TX NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$339.87
- Category: General Payments
- Program years: PY2022–2024
- Record count: 20
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $152.48 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $152.48 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.83 | 1 |
| PFIZER INC. | $21.55 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.55 | 1 |
| UCB, Inc. | $18.09 | 1 |
| ACADIA Pharmaceuticals Inc | $17.85 | 1 |
| Celgene Corporation | $16.20 | 1 |
| ARGENX US, INC. | $15.92 | 1 |
| Neurelis, Inc. | $15.49 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086949473 | Novartis Pharmaceuticals Corporation | $27.83 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101099054 | Celgene Corporation | $16.20 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131915007 | PFIZER INC. | $21.55 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137767475 | Takeda Pharmaceuticals U.S.A., Inc. | $19.55 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142144717 | ARGENX US, INC. | $15.92 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143407585 | UCB, Inc. | $18.09 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145665330 | Neurelis, Inc. | $15.49 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148005828 | ACADIA Pharmaceuticals Inc | $17.85 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.